Koya Medical (“Koya”), an emerging medtech innovator advancing patient-centered solutions in vascular health, has announced its participation in the Piper Sandler 37th Annual Healthcare Conference on Tuesday, December 2, 2025 at 1:50 pm ET at the Lotte New York Palace.
https://mma.prnewswire.com/media/2707057/Koya_Medical_Logo.jpg
Andy Doraiswamy (CEO) and Damian Rippole (CFO) will highlight the company's ongoing clinical research, provide updates on commercial momentum for its portfolio-including Dayspring® non-pneumatic compression treatment for chronic edema-and share progress on its vascular pipeline.
About Koya Medical
Founded in 2018 and headquartered in Dallas, Koya Medical is redefining vascular health with patient-centered solutions designed to support care from clinic to home. Inspired by a personal journey with vascular disease, Koya's mission is to close treatment gaps -starting with its FDA-cleared Dayspring treatment system and advancing its pipeline.
Why Vascular Health Matters
More than 35 million Americans live with venous and lymphatic diseases-serious yet often overlooked conditions that can severely impact mobility, quality of life, and long-term health-highlighting the urgent need for modern, evidence-based, and scalable solutions.
Learn more atwww.koyamedical.com and follow Koya onLinkedIn.
https://edge.prnewswire.com/c/img/favicon.png?sn=SF33354&sd=2025-11-26
View original content to download multimedia:https://www.prnewswire.com/news-releases/koya-medical-to-present-at-the-piper-sandler-37th-annual-healthcare-conference-302626814.html
SOURCE Koya Medical
https://rt.newswire.ca/rt.gif?NewsItemId=SF33354&Transmission_Id=202511260938PR_NEWS_USPR_____SF33354&DateId=20251126